Literature DB >> 30611956

An analysis of plasma reveals proteins in the acute phase response pathway to be candidate diagnostic biomarkers for depression.

Qi Wang1, Chunyue Yu1, Shanshan Shi1, Xiaojie Su2, Jian Zhang3, Yongqing Ding4, Yanan Sun1, Min Liu1, Chunquan Li3, Xiwu Zhao5, Wenhai Jiang5, Taiming Wei6.   

Abstract

Globally, depression is one of the most serious debilitating psychiatric mental disorders. In this study, we validated the expression levels of fibrinogen alpha (FGA), fibrinogen beta (FGB), fibrinogen gamma (FGG), Complement factor B (CFB) and serpin family D member 1(SERPIND1) in the acute phase response signaling pathway in plasma samples using enzyme-linked immunosorbent assay (ELISA).Then illuminate the roles of FGA, FGB, FGG, CFB, SERPIND1 in depression using microarray data. Gene expression dataset GSE98793 was downloaded from the Gene Expression Omnibus database. There were 128 whole blood samples included 64 patients with major depressed patients and 64 healthy controls. Differentially expressed genes (DEGs) were identified, and then protein-protein interaction (PPI) network was constructed to screen crucial genes associated with FGA, FGB, FGG, CFB and SERPIND1. Moreover, gene ontology (GO) biological processes analyses was performed. The ELISA data showed that the expression levels of FGA, FGB, FGG, CFB and SERPIND1 were up-regulated in depressed patients. The enriched GO terms were predominantly associated with the biological processes including more genes were inflammation related. The PPI network was found these five genes interacted with 11 genes. FGA, FGB, FGG, CFB and SERPIND1 may be important in the pathogenesis of depression.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Bioinformatics; Biomarkers; Depression; Human; Pathway; Serum

Mesh:

Substances:

Year:  2018        PMID: 30611956     DOI: 10.1016/j.psychres.2018.11.069

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Perturbation of Ephrin Receptor Signaling and Glutamatergic Transmission in the Hypothalamus in Depression Using Proteomics Integrated With Metabolomics.

Authors:  Yu Wu; Zhenhong Wei; Yonghong Li; Chaojun Wei; Yuanting Li; Pengfei Cheng; Hui Xu; Zhenhao Li; Rui Guo; Xiaoming Qi; Jing Jia; Yanjuan Jia; Wanxia Wang; Xiaoling Gao
Journal:  Front Neurosci       Date:  2019-12-17       Impact factor: 4.677

2.  Wfs1 and Related Molecules as Key Candidate Genes in the Hippocampus of Depression.

Authors:  Jing Yang; Chaoqin Chen; Xiaoyuan Jin; Lu Liu; Jiajia Lin; Xianhui Kang; Shengmei Zhu
Journal:  Front Genet       Date:  2021-01-22       Impact factor: 4.599

3.  Chronic D-ribose and D-mannose overload induce depressive/anxiety-like behavior and spatial memory impairment in mice.

Authors:  Ke Xu; Mingyang Wang; Wei Zhou; Juncai Pu; Haiyang Wang; Peng Xie
Journal:  Transl Psychiatry       Date:  2021-02-02       Impact factor: 6.222

4.  Emodin Prevented Depression in Chronic Unpredicted Mild Stress-Exposed Rats by Targeting miR-139-5p/5-Lipoxygenase.

Authors:  Teng Zhang; Can Yang; Jiang Chu; Lin-Na Ning; Peng Zeng; Xiao-Ming Wang; Yan Shi; Bao-Jian Qin; Na Qu; Qi Zhang; Qing Tian
Journal:  Front Cell Dev Biol       Date:  2021-07-26

5.  Gill and Liver Transcript Expression Changes Associated With Gill Damage in Atlantic Salmon (Salmo salar).

Authors:  Mohamed Emam; Albert Caballero-Solares; Xi Xue; Navaneethaiyer Umasuthan; Barry Milligan; Richard G Taylor; Rachel Balder; Matthew L Rise
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

6.  Inflammatory Pathways in Psychiatric Disorders: The case of Schizophrenia and Depression.

Authors:  Tami Feng; Ashutosh Tripathi; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2020-07-26

7.  Effects of venlafaxine on the expression level and methylation status of genes involved in oxidative stress in rats exposed to a chronic mild stress.

Authors:  Paulina Wigner; Ewelina Synowiec; Piotr Czarny; Michal Bijak; Paweł Jóźwiak; Janusz Szemraj; Piotr Gruca; Mariusz Papp; Tomasz Śliwiński
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.